West Pharmaceutical Services, Inc. (WST) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Instruments & Supplies secteur d'activité. Le siège social de l'entreprise est situé à Exton, PA, United States. Le PDG actuel est Eric Green.
WST a date d'introduction en bourse 1980-03-17, 10,600 employés à temps plein, cotée sur le NYSE, une capitalisation boursière de $19.3B.
West Pharmaceutical Services, Inc. is a leading global manufacturer of containment and delivery systems for injectable drugs and healthcare products, serving pharmaceutical, biologic, and medical device companies across the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through two main segments: Proprietary Products, which includes stoppers, seals, syringe components, self-injection devices, and its proprietary Crystal Zenith polymer platform for vials and cartridges; and Contract-Manufactured Products, which provides design and assembly services for surgical, diagnostic, ophthalmic, and drug delivery devices. Beyond manufacturing, West offers comprehensive support services including analytical testing, regulatory expertise, engineering development, and after-sales technical support to enhance product quality and safety. Founded in 1923 and headquartered in Exton, Pennsylvania, the company distributes its products through a global network of sales representatives, distributors, and contract agents.
